Although evidence indicates that TSP1 and TSP2 are upregulated in tumors and play antiangiogenic roles leading to antitumor effects [22–24], the carcinogenic role of TSP1 that results in increased aggressiveness in glioma should not be ignored [25–28]. This evidence concerns the gene THBS2 and central nervous system cancer.